Company

Immunotec 20th Anniversary Top 100

Investor relations

Immunotec Inc. is a Canadian-based company ranked in the Direct Selling News Global 100 list in 2015. The Company develops, manufactures, markets, and sells an extensive family of research-driven nutritional products targeting health, wellness, and weight management, as well as energy and fitness through direct-to-consumer sales channels in Canada, the United States, and Mexico. The Immunocal family of products is supported by over 40 published articles and supporting science in the medical and scientific literature.

The Company files its continuous disclosure documents on the SEDAR database at www.sedar.com and on the Company's website.

Shareholder information

  • Auditors: PricewaterhouseCoopers
  • Registrar and Transfer Agent: Computershare Trust Company of Canada
  • Investor Relations: Patrick Montpetit, CA, CF, Vice-President and Chief Financial Officer, 450‑424‑9992
  • Stock Exchange Listing: TSX Venture Exchange, Symbol: IMM

Stock information

  • Company Name: Immunotec Inc.
  • Instrument Symbol: IMM
  • Instrument Name: Immunotec Inc.

Annual reports

2015 / 2014 / 2013 / 2012 / 2011 / 2010 / 2009 / 2008 / 2007 / 2006 / 2005

Quarterly reports

Management discussion and analysis

2016 Q1 Q2 Q3
2015 Q1 Q2 Q3 Q4
2014 Q1 Q2 Q3 Q4
2013 Q1 Q2 Q3 Q4
2012 Q1 Q2 Q3 Q4
2011 Q1 Q2 Q3 Q4
2010 Q1 Q2 Q3 Q4
2009 Q1 Q2 Q3 Q4
2008 Q1 Q2 Q3 Q4
2007 Q1 Q2 Q3 Q4

Financial statements

2016 Q1 Q2 Q3
2015 Q1 Q2 Q3 Q4
2014 Q1 Q2 Q3 Q4
2013 Q1 Q2 Q3 Q4
2012 Q1 Q2 Q3 Q4
2011 Q1 Q2 Q3 Q4
2010 Q1 Q2 Q3 Q4
2009 Q1 Q2 Q3 Q4
2008 Q1 Q2 Q3 Q4
2007 Q1

Investor information and annual information form

Proxy circular

2015 / 2010 / 2009 / 2008 / 2007 / 2005 / 2004

Audit and disclosure policy

Audit and disclosure policy